<code id='F24C575273'></code><style id='F24C575273'></style>
    • <acronym id='F24C575273'></acronym>
      <center id='F24C575273'><center id='F24C575273'><tfoot id='F24C575273'></tfoot></center><abbr id='F24C575273'><dir id='F24C575273'><tfoot id='F24C575273'></tfoot><noframes id='F24C575273'>

    • <optgroup id='F24C575273'><strike id='F24C575273'><sup id='F24C575273'></sup></strike><code id='F24C575273'></code></optgroup>
        1. <b id='F24C575273'><label id='F24C575273'><select id='F24C575273'><dt id='F24C575273'><span id='F24C575273'></span></dt></select></label></b><u id='F24C575273'></u>
          <i id='F24C575273'><strike id='F24C575273'><tt id='F24C575273'><pre id='F24C575273'></pre></tt></strike></i>

          knowledge

          knowledge

          author:comprehensive    Page View:345
          Good CEOs 2022
          Hyacinth Empinado/STAT

          It’s that time of the year again when I recognize the Best Biopharma CEO of the year.

          This year’s selection is so deservingly obvious that I won’t fabricate suspense by starting with an honor roll of runners-up. More on those high-achieving folks later. Let’s get right to the main course: David Ricks of Eli Lillyis the runaway, rock star, who-else-could-it-be Best Biopharma CEO of 2023.

          advertisement

          What an incredible year it’s been for Ricks and the Lilly executive team who helped him achieve so much. My colleague Matt Herper wrote earlier this year about the “dynamic duo” of Ricks and Chief Scientific Officer Dan Skovronsky.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          Wikipedia

          Supreme Court strikes down use of affirmative action
          Supreme Court strikes down use of affirmative action

          ActivistsdemonstratedastheSupremeCourtheardoralargumentsonapairofaffirmativeactioncasesinOctober2022

          read more
          Roche acquires Telavant from Roivant, adding experimental IBD treatment
          Roche acquires Telavant from Roivant, adding experimental IBD treatment

          SebastienBozon/AFPviaGettyImagesRochesaidMondayitwasbuyingTelavantHoldingsfor$7.1billionupfront,pick

          read more
          As demand for Covid shots wanes, Moderna seeks its next success
          As demand for Covid shots wanes, Moderna seeks its next success

          RubyWallauforSTATModernachairmanNoubarAfeyanexudedstarpowerearlierthismonthashecommandedthespotlight

          read more

          How AI can help patients find reliable information about doctors

          AdobeAlmostassoonasChatGPTwasreleasedtothepublic,doctorsbeganfocusingonhowtheycouldharnessartificial